BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  BioMidwest

  Gates and His Rich Buddies Back Exicure’s $11.2M Funding Round

  Exicure announced it had closed on $11.2M in private financing.

  November 6, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Valeant Sells Sprout Pharma to a New Company ‘Associated’ With Sprout Founders

  A little more than two years after acquiring Sprout, Valeant is selling off the developer of the female sex drive drug Addyi.

  November 6, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Politically Connected Patrick Soon-Shiong Questioned Over Genetic Tests

  Patrick Soon-Shiong touted sales of his closely scrutinized test without revealing the purchaser was on his payroll.

  November 6, 2017

   · 

  1 min read
• Business

  Guangzhou Pharma May Form China Generics JV With Teva Pharma

  November 6, 2017

   · 

  1 min read
• 

  Policy

  TherapeuticsMD Soars on Plans to Resubmit TX-004HR NDA Without New Pre-Approval Study

  Shares of TherapeuticsMD have shot up more than 51 percent in morning trading after the FDA reversed course on its rejection of that company’s vaginal pain medication.

  November 6, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  Enesi Pharma Appoints New International Scientific Advisory Board

  The SAB includes experts in vaccines and preventative health from leading academic/ research and international health organisations in the US and Europe.

  November 6, 2017

   · 

  3 min read
• 

  Business

  Layoffs in California: Amgen to Slash 200 R&D Jobs, Genentech to Cut 130

  It’s not uncommon for companies to announce layoffs in the final months of the year.

  November 6, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Two-Year Old Biotech NousCom Nabs $49M to Fund New Drug Into Clinic

  The round was led by new investor Abingworth with participation from another new investor, 5AM Ventures, LSP and Versant Ventures.

  November 6, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Billionaire Businessman Looking to Take Stake in Debt-Ridden Teva

  Shares of Teva are up more than 5 percent this morning after Israeli media reported billionaire businessman Len Blavatnik is considering taking a large stock position in the pharma giant.

  November 6, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  WuXi Biologics Partners With Pall to Reduce mAb Production Costs

  The 3-year project aims to lower the cost of manufacturing mAbs significantly - to $5/g.

  November 6, 2017

   · 

  1 min read